in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/fine chemicals roundup—19 November 2013
3:23 AM MST | November 19, 2013 | Deepti Ramesh
DSM and JLL form $2-billion pharma services firm by merging DSM Pharmaceutical Products with Patheon DSM and JLL Partners (New York), a middle-market private equity firm, will create a new company, which will be a leading global contract development and manufacturing organization (CDMO) for the pharmaceutical industry, with anticipated sales of about $2 billion in 2014, DSM says. The company will be formed by combining DSM Pharmaceutical Products (Parsippany, NJ), the custom manufacturing and technology business of DSM, with Patheon (Toronto), a portfolio company...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee